CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $2700.00 per share for the 12-month period ending 2014-12-27, per its 10-K filed 2015-02-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2015-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2014-09-27 was $680.00, a 13.33% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2014-06-28 was $0.74, a 51.02% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2013-09-28 was $600.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2013-06-29 was $0.49.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2014 was $2700.00, a 33.00% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2013 was $2030.00, a 14.69% increase from fiscal 2012.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2012 was $1770.00.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2014-12-27 | $2700.00 10-K · filed 2015-02-17 | |||
| 2014-09-27 | $680.00 10-Q · filed 2014-10-30 | $2120.00 10-Q · filed 2014-10-30 | ||
| 2014-06-28 | $0.74 10-Q · filed 2014-08-07 | $1.38 10-Q · filed 2014-08-07 | ||
| 2013-12-28 | $2030.00 10-K · filed 2015-02-17 | |||
| 2013-09-28 | $600.00 10-Q · filed 2014-10-30 | $1580.00 10-Q · filed 2014-10-30 | ||
| 2013-06-29 | $0.49 10-Q · filed 2014-08-07 | $1.00 10-Q · filed 2014-08-07 | ||
| 2012-12-29 | $1770.00 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |